Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that limits airflow from the lungs and can make breathing difficult. The ...

Study found that 69% of hospitalized COPD patients misused inhalers, with 66% making critical errors, and 14% having insufficient Peak Inspiratory Flow (PIF), even after training.

To better characterize the prevalence of and factors associated with inhaler misuse in hospitalized patients with COPD, the researchers reviewed data from consecutive patients with COPD who were ...

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization ...

Inhalers and nebulizers are vital in treating COPD. But how do you know which one is right for you? Here’s a rundown to keep you informed.

New Advances in Treatment: In the past, treatments for COPD flares included inhalers, steroids, and antibiotics. Recently, the FDA approved new injectable medications called biologics.

Inhaler misuse leading to inadequate medication delivery impacts a person’s ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

Adults with asthma and/or COPD who received 23 text messages about preventer inhaler use over 26 weeks had improved inhaler adherence, according to a poster presented at the European Respiratory ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD exacerbations and pneumonia risk.